Toward the end of trading Thursday, the Dow was down 0.10
percent to 15,259.91, while the NASDAQ rose 0.13 percent to
3,476.15. The S&P traded down, falling 0.23 percent to
Top Headline US stocks saw some volatility on Thursday,
fluctuating between gains and losses, following the disappointing
economic data released this morning. While housing starts
witnessed a decline, initial jobless claims were up and
manufacturing in the Philadelphia region slumped.
While Walmart's (NYSE:
) shares plummeted 2.2 percent, Cisco (NASDAQ:
) helped to lift the NASDAQ, after the latter company reported
its fiscal third quarter earnings above the analyst expectations.
Cisco's CEO, John Chambers, said that the company was witnessing
positive signs in the US and other parts of the world.
Equities Trading UP Cisco Systems, Inc (NASDAQ:
) shot up 13.13 percent to $23.99, breaking through the ceiling
that has capped the stock for over two years. Analysts believe
that the tech giant is in for a long-term rally, fuelled by the
better than expected fiscal Q3 results and upbeat outlook.
Aegerion Pharmaceuticals, Inc (NASDAQ:
) got a boost, shooting up 34.71 percent to $63.32. Aegerion
Pharmaceuticals' five year expected PEG ratio is 0.29.
Halozyme Therapeutics, Inc (NASDAQ:
) was also up, gaining 16.17 percent to $7.84. Halozyme is
scheduled to report clinical data from Phase 1b trial of PEGPH20
(PEGylated Recombinant Human Hyaluronidase), an investigational
new biologic, at the annual meeting of the American Society of
Clinical Oncology (
Equities Trading DOWN Advanced Micro Devices, Inc (NYSE:
) was down, falling 13.42 percent to $3.79, after Goldman Sachs
downgraded its rating on Advanced Micro Devices from "neutral" to
"sell," despites raising its estimates for the company.
Infinity Pharmaceuticals, Inc (NASDAQ:
) was down 20.58 percent to $24.97. Infinity Pharmaceuticals is
scheduled to announce Phase 1 clinical data for IPI-145 at the
annual meeting of the American Society of Clinical Oncology (
) and at the 12th International Conference on Malignant Lymphoma
Optimer Pharmaceuticals (NASDAQ:
) was down as well, falling 6.12 percent to $15.19 after the
company has seen bids from Cubist before the company's sale
process had formally began, making waves in the regulatory
Commodities In commodity news, oil traded up 0.90 percent to
$95.15, while gold declined 0.68 percent to $1386.50.
Silver also fell, rising 0.83 percent Thursday to $22.79,
while copper was up 0.96 percent to $3.29.
Euro zone European shares were also mixed overnight on
economic data. The Spanish Ibex Index fell 0.15 percent and the
Italian FTSE MIB Index rose 0.39 percent. Meanwhile, the German
DAX fell 0.2 percent and the French CAC 40 declined 0.31 percent
while U.K. shares rose 0.06 percent.
Economics The Bloomberg Consumer Comfort Index was flat this
week, after seeing the best month in over five years. The figures
implied a reversal in consumer confidence, while analysts had
expected a rise.
The Philadelphia Fed Survey shows a significant contraction in
Thursday's manufacturing report for the Mid-Atlantic region. On
the other hand, the EIA Natural Gas Report shows an increase in
storage to 99 billion cubic for the week ended June 13
(c) 2013 Benzinga.com. Benzinga does not provide investment
advice. All rights reserved.
Profit with More New & Research
. Gain access to a streaming platform with all the information
you need to invest better today.
Click here to start your 14 Day Trial of Benzinga